Common Contracts
7 similar Continuing Unconditional Secured Guaranty contracts by Acura Pharmaceuticals, Inc
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • January 31st, 2006 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made on January 31, 2006 by Acura Pharmaceutical Technologies, Inc., an Indiana corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • November 10th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made on November 9, 2005 by Acura Pharmaceutical Technologies, Inc., an Indiana corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • November 10th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made on November 9, 2005 by Axiom Pharmaceutical Corporation, a Delaware corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • September 16th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made on September 16, 2005 by Axiom Pharmaceutical Corporation, a Delaware corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • September 16th, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made on September 16, 2005 by Acura Pharmaceutical Technologies, Inc., an Indiana corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • June 23rd, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made as of June 22, 2005 by Axiom Pharmaceutical Corporation, a Delaware corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
CONTINUING UNCONDITIONAL SECURED GUARANTYContinuing Unconditional Secured Guaranty • June 23rd, 2005 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This Continuing Unconditional Secured Guaranty (“Guaranty”) is made as of June 22, 2005 by Acura Pharmaceutical Technologies, Inc., an Indiana corporation (“Guarantor”) in favor of Galen Partners III, L.P., a Delaware limited partnership, acting in its capacity as agent for the Lenders, as defined below (“Agent”), for the benefit of the Lenders.
